| Literature DB >> 34345955 |
Enzamaria Fidilio1,2, Marta Comas2,3, Miguel Giribés2, Guillermo Cárdenas2, Ramón Vilallonga1,4, Fiorella Palma2, Rosa Burgos Peláez1,2, Rafael Simó5,6,7,8, Andreea Ciudin9,10,11.
Abstract
PURPOSE: One major determinant of weight loss is resting energy expenditure (REE). However, data regarding REE is scarce in patients with severe obesity (SO)-BMI>50kg/m2. Most studies used equation in order to estimate REE and not indirect calorimetry (IC) (gold standard). Additionally, there is no reliable data on the impact of bariatric surgery (BS) on REE.Entities:
Keywords: Bariatric surgery; Resting energy expenditure; Severe obesity
Mesh:
Year: 2021 PMID: 34345955 PMCID: PMC8458189 DOI: 10.1007/s11695-021-05578-5
Source DB: PubMed Journal: Obes Surg ISSN: 0960-8923 Impact factor: 4.129
Fig. 1Flowchart of the inclusion of the patients in the study. BMI, body mass index; BS, bariatric surgery; IC, indirect calorimetry; RYGB, Roux-en-Y gastric bypass; SG, sleeve gastrectomy
Baseline characteristics of patients with severe obesity
| Gender, females, % ( | 64.10 (25) | |
| Age (years), mean (SD) | 46.5 ± 11.7 | |
| Initial weight (kg), mean (SD) | 149.3 ± 30.36 | |
| BMI (kg/m2), mean (SD) | 56.2 ± 5.6 | |
| EW (kg), Mean (SD) | 83.1 ± 22.3 | |
| Type 2 diabetes, % ( | 30.8 (12) | |
| Hypertension, % ( | 38.5 (15) | |
| Dyslipidemia, % ( | 17.9 (7) | |
| OSA, % ( | Absent Mild Moderate Severe | 20.5 (8) 15.4 (6) 5.1 (2) 59 (23) |
| Number of obesity-related comorbidities, % ( | None 1 2 3 4 | 10.3 (4) 17.9 (7) 35.9 (14) 20.5 (8) 15.3 (6) |
BMI body mass index, EW excess of weight, NAFLD non-alcoholic fatty liver disease, OSA obstructive sleep apnea
Follow-up subgroup characteristics
| Age (years) | 50.44± 7.52 | ||||
| Sex, females, % ( | 67.7 (21) | ||||
| Type of surgery, % ( | SG 77.4 (24) RYGB 22.6 (7) | ||||
| Weight (kg) | 135.98±20.11a | 92.08±23.22a | 88.35±24.12a | 94.37±24.67a | |
| BMI (kg/m2) | 53.66±3.35a | 36.13±6.06a | 34.60±6.29a | 37.04±6.02a | |
| EW (kg) | 72.51±11.98a | 27.61±18.54a | 24.89±18.54a | 30.91±18.36a | |
| Type 2 diabetes, % ( | 45.2 (14) | 6.4 (2) | 6.4 (2) | 19.3 (6) | |
| Hypertension, % ( | 38.7 (12) | 12.9 (4) | 12.9 (4) | 12.9 (4) | |
| Dyslipidemia, % ( | 25.8 (8) | 6.4 (2) | 6.4 (2) | 12.9 (4) | |
| OSA,% ( | Absent Mild Moderate Severe | 45.2 (14) 12.9 (4) 32.2 (10) 12.9 (4) | 61.3 (19) 32.2 (10) 6.4 (2) 0 (0) | 61.3 (19) 32.2 (10) 6.4 (2) 0 (0) | 51.6 (16) 22.5 (7) 12.9 (4) 6.4 (2) |
Percent of total weight loss (%TWL) %TWL> 20, % ( | 32.34±12.06a 83.87 (26) | 35.13±12.58a 87.01 (27) | 30.74± 12.49a 74.1 (23) | ||
Percent excess weight loss (%EWL) %EWL >50, % ( | 60.44±20.76a 64.5 (20) | 65.67±21.78a 80.6 (25) | 57.32 ± 21.58a 67.7 (21) | ||
BMI body mass index, EW excess of weight, FU follow-up, OSA obstructive sleep apnea, RYGB Roux-en-Y gastric bypass, SG sleeve gastrectomy. Continuous variables expressed in mean ± SD. aRepeated-measures ANOVA, p < 0.001
Figure 2Changes in measured resting energy expenditure and body mass index before and after bariatric surgery. BMI, body mass index; mREE, measured resting energy expenditure; 1m, 1 month after bariatric surgery; 12m, 12 months after bariatric surgery. Repeated-measures ANOVA for: A BMI and B mREE before and after BS, p < 0.001. Results after Bonferroni correction are indicated if significant differences were found. *p < 0.05; **p < 0.01
Changes in energy metabolism
| mREE (kcal/day) | 2320.4 ± 750.8a | 1537.7 ± 83.7a, b | 1526.0 ± 3.7b | 0.006 |
| MSJ (kcal/day) | 1994.4 ± 463.4a | 1789.1 ± 307.5a | 1551.1 ± 349.8a | 0.001 |
| RQ (VCO2/ VO2) | 0.81 ± 0.13 | 0.79 ± 0.08 | 0.81 ± 0.07 | n.s |
mREE measured resting energy expenditure, MSJ Mifflin St-Jeor equation, RQ respiratory quotient, V oxygen consumption (ml/min−1), V carbon dioxide production (ml/min−1). Continuous variables expressed in mean ± SD
ǂRepeated-measures ANOVA
aBonferroni correction p <0.005
bBonferroni correction p =n.s
Differences among gender in mREE and MSJ across three time points
| mREE (kcal/day) | Female | 1769.36±245.81a | 1529.45±100.74 | 1526.0±95.55b |
| Male | 2561.0±449.40a | 1555.73±40.40b | 1548±72.32 | |
| MSJ (kcal/day) | Female | 1778.36±97.92a | 1604.73±97.62a | 1393.91±107.31a, b |
| Male | 2469.80±245.79a | 2194.80±177.32a, b | 1896.80±461.10a | |
| RQ | Female | 0.92±0.19a | 0.81±0.02 | 0.81±0.09 |
| Male | 0.78±0.01a | 0.79±0.10 | 0.80±0.01 | |
aSignificant difference between women and men p <0.05 bSignificant difference between gender and mREE or MSJ p<0.05
Figure 3The predictive capacity of the reduction in mREE at 12 months from baseline for: A EWL<50% at nadir and B weight regain after 5 years follow-up